Complexa Inc. is a clinical-stage biopharmaceutical company based in Berwyn, Pennsylvania, developing nitrated fatty acids (NFAs) for the treatment of debilitating fibrotic and inflammatory orphan diseases. Its lead compound CXA-10 is in Phase 2 development for focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH). Investors include NEA, Pfizer Venture Investments, Andera Partners, HBM Healthcare Investments, and JAFCO.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountJan 2013
Jun 2012
Create a free account to see which investors have funded this company.
Create Free AccountClinical-stage biotech developing small-molecule therapeutics targeting galectin and other mechan...
Arcellx is a clinical-stage biopharmaceutical company developing novel, adaptive and controllable...
A clinical-stage biopharma company based in Lyon, France
Clinical-stage biopharmaceutical company focused on the development of oral small molecule therap...
Centrexion Therapeutics Corp. is focused on advancing the treatment of chronic moderate to severe...
Addex Therapeutics is a biopharmaceutical company focused on the development of novel, orally ava...
